Portfolio
Our team has completed portfolio company investments in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology spaces. We have backed multiple market leaders, including the selection of current and exited portfolio companies highlighted here.
Adams Respiratory Therapeutics, Inc.
Adams was a specialty pharmaceutical company focused on late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Sector
Specialty Pharma
Status
Exited | IPO; subsequently acquired by Reckitt Benckiser
Alphatec Spine, Inc.
Alphatec Spine, Inc. (Nasdaq: ATEC) is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction via its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc. Its Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with its expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery.
Sector
Medtech and Medical Devices
Status
Current
Website
https://atecspine.com/
Atritech, Inc.
Atritech developed WATCHMAN™, an implantable device for preventing stroke in atrial fibrillation patients.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Boston Scientific
Channel Medsystems
Channel Medsystems, Inc. is a privately held medical device company headquartered in Berkeley, CA. The company’s mission is to empower every woman to take control of her health journey and live her best life. Channel Med’s lead product is the Cerene Cryotherapy Device (“Cerene”), which provides an endometrial ablation treatment using cooling technology (cryoablation) that can significantly reduce menstrual bleeding and dysmenorrhea. Cerene’s in-office treatment does not require general anesthesia. The use of cryotherapy also results in a unique healing profile that can preserve access to the uterine cavity for future diagnostic evaluations.
Sector
Medical Devices
Status
Current
Website
https://cerene.com/
Coherex Medical, Inc.
Coherex developed the WaveCrest® Left Atrial Appendage (LAA) Occlusion System, designed to permanently occlude the LAA in high-risk atrial fibrillation (Afib) patients to help reduce the incidence of stroke.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Biosense Webster/J&J
DocMatter
DocMatter is a global medical specialist platform that provides information sharing by leveraging the collective knowledge and experience of peers, as well as that of thought leaders from leading institutions and practices around the world. The company’s two-pronged subscription SAAS model creates value for all stakeholders – specialty societies and sales representatives alike – with no advertising.
Sector
Healthcare Services and Technology
Status
Current
Website
https://www.docmatter.com/
electroCore, Inc.
electroCore, Inc. (Nasdaq: ECOR) is a commercial-stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. The company is focused on commercializing medical devices for managing and treating certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the US and select overseas markets.
Sector
Medtech and Medical Devices
Status
Current
Website
https://www.electrocore.com/
Exagen, Inc.
Exagen, Inc. (Nasdaq: XGN) is a leading provider of autoimmune testing with a mission to provide clarity in decision-making and improve clinical outcomes through its innovative portfolio. Flagship product AVISE® CTD enables clinicians to more effectively diagnose complex autoimmune conditions earlier and with greater accuracy. Exagen’s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring.
Sector
Biotechnology
Status
Current
Website
https://exagen.com
Genoptix, Inc.
Genoptix is a leading clinical oncology laboratory specializing in hematology and solid tumors, and operates one of the largest hematopathology centers in the U.S., providing personalized and comprehensive diagnostic services with a specialization in diagnosing cancers and disorders in bone marrow, blood and lymph nodes, as well as in solid tumor workups using molecular testing.
Sector
Healthcare Services and Technology
Status
Exited | IPO; subsequently acquired by Novartis
Website
https://genoptix.com
Ikano Therapeutics, Inc.
Ikano developed Nayzilam® (midazolam) nasal spray CIV, a benzodiazepine indicated for the acute treatment of intermittent stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 12+ years of age.
Sector
Specialty Pharma
Status
Exited | Acquired by Upsher Smith Laboratories
Impulse Monitoring, Inc.
Impulse provided remote, real-time neurophysiology monitoring during spinal and cranial surgeries, procedures that present direct risk to the nervous system.
Sector
Healthcare Services and Technology
Status
Exited | Acquired by NuVasive
Newton
Newton is an innovation company redefining eye care through exceptional patient experiences and outcomes. With patented Contoured Prism™ and Convergence Boost™ technologies, Newton empowers eye care providers to bring real relief to patients while elevating the standard of care across the industry.
Sector
Medtech and Medical Devices
Status
Current
Website
https://newton.tech/
Sirion Therapeutics, Inc.
Sirion developed and commercialized products that addressed unmet medical needs in the protection and preservation of eyesight. Its lead products are now on the market for post-operative inflammation and ocular herpes.
Sector
Specialty Pharma
Status
Exited | Acquired by Alcon and Bausch & Lomb
Synageva BioPharma Corp.
Synageva developed and commercialized therapies for underserved populations with rare conditions and unmet medical needs.
Sector
Biotechnology
Status
Exited | IPO; subsequently acquired by Alexion Pharmaceuticals
TriSalus Life Sciences
TriSalus Life Sciences® (Nasdaq: TLSI) is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Its platform includes devices that utilize a proprietary drug delivery technology and a clinical-stage investigational immunotherapy.
Sector
Medtech and Medical Devices
Status
Current
Website
https://trisaluslifesci.com
Vidacare Corporation
Vidacare was the developer of intraosseous (inside the bone) medical devices used in vascular access, emergency and disaster medicine, oncology, and spinal surgery and marketed in over 50 countries worldwide. Its EZ-IO technology was used in 90 percent of U.S. advanced life support ambulances, over half of U.S. emergency departments, and by the U.S. military.
Sector
Medtech and Medical Devices
Status
Exited | Acquired by Teleflex